Virtual Reality Distraction in Patients Undergoing Periodontal Surgery

Sponsor
Kutahya Health Sciences University (Other)
Overall Status
Completed
CT.gov ID
NCT06092177
Collaborator
(none)
58
1
2
12
4.8

Study Details

Study Description

Brief Summary

The goal of this randomized controlled clinical trial is to evaluate the effect of virtual reality technology on anxiety and pain levels in patients undergoing periodontal surgery.

Participants will be randomly assigned into test and control groups. While the patients in the test group will undergo periodontal surgery with virtual reality distraction, the patients in the control group without distraction. After treatment, the groups will be compared regarding anxiety and pain levels.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Periodontal surgery with virtual reality distraction
  • Procedure: Periodontal surgery without virtual reality distraction
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Virtual Reality Distraction on Dental Anxiety in Patients Undergoing Periodontal Surgery
Actual Study Start Date :
May 2, 2022
Actual Primary Completion Date :
Apr 3, 2023
Actual Study Completion Date :
May 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Test group

The group will include patients who undergo periodontal surgery with virtual reality distraction

Procedure: Periodontal surgery with virtual reality distraction
Periodontal surgery to improve gingival contour and eliminate inflamed periodontal pockets

Experimental: Control group

The group will include patients who undergo periodontal surgery without virtual reality distraction

Procedure: Periodontal surgery without virtual reality distraction
Periodontal surgery to improve gingival contour and eliminate inflamed periodontal pockets

Outcome Measures

Primary Outcome Measures

  1. Anxiety level [Preoperative, immediately postoperative]

    Modified dental anxiety scale where higher scores mean a worse outcome and has a minimum value of 5 and a maximum value of 25

Secondary Outcome Measures

  1. Pain level [Preoperative, immediately postoperative]

    Visual analog scale where higher scores mean a worse outcome and has a minimum value of 0 and a maximum value of 10

  2. Systolic blood pressure [Preoperative, intraoperative, immediately postoperative]

    Blood pressure will be measured by a sphygmomanometer.

  3. Diastolic blood pressure [Preoperative, intraoperative, immediately postoperative]

    Blood pressure will be measured by a sphygmomanometer.

  4. Heart rate [Preoperative, intraoperative, immediately postoperative]

    The frequency of the heartbeat measured by the number of contractions of the heart per minute

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Individuals over the age of 18

  • Systemically healthy patients

  • Need for periodontal surgical treatment in the mandibular anterior region

  • Scoring 15 or above on the modified dental anxiety scale

Exclusion Criteria:
  • Having a history of seizures or a convulsive disorder

  • Balance disorders such as nystagmus, vertigo

  • Use of psychotropic drugs

  • Getting treatment for anxiety

  • Presence of dermatological lesions on the face, especially around the eyes

  • A lesion in the eye that will prevent the use of virtual reality glasses

  • Systemic disease and medication use that contraindicate periodontal surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kutahya Health Sciences University Kutahya Turkey 43100

Sponsors and Collaborators

  • Kutahya Health Sciences University

Investigators

  • Principal Investigator: Ezgi Gurbuz, Kutahya Health Sciences University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ezgi Gürbüz, Assistant Professor, Kutahya Health Sciences University
ClinicalTrials.gov Identifier:
NCT06092177
Other Study ID Numbers:
  • 03
First Posted:
Oct 23, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 23, 2023